Scholar Rock
Trade Scholar Rock 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SRRK
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
SRRK Key Statistics
Stock Snapshot
The current Scholar Rock(SRRK) stock price is $48.55, with a market capitalization of 5.61B. The stock trades at a price-to-earnings (P/E) ratio of -14.25.
On 2026-04-06, Scholar Rock(SRRK) stock moved within a range of $48.55 to $50.41. With shares now at $48.55, the stock is trading 0.0% above its intraday low and -3.7% below the session's peak.
Trading volume for Scholar Rock(SRRK) stock has reached 1.28M, versus its average volume of 2.06M.
The stock's 52-week range extends from a low of $22.71 to a high of $50.50.
The stock's 52-week range extends from a low of $22.71 to a high of $50.50.
SRRK News
On 31 March 2026, Scholar Rock announced it had resubmitted its Biologics License Application to the FDA for apitegromab in spinal muscular atrophy, now incorpo...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Scholar Rock Holding (SRRK) stock soared on Tuesday after the biopharmaceutical company announced it has resubmitted the Biologics License Application (BLA) for...
Analyst ratings
100%
of 16 ratingsMore SRRK News
Scholar Rock (SRRK) announced it has resubmitted the Biologics License Application, BLA, for apitegromab for the treatment of children and adults with Spinal Mu...